ImmuneMed
http://immunemed.tradekorea.com
People
are free from the threat and burden of diseases by medical technologies. ImmuneMed
introduces a diagnostic kit for acute illnesses that will save numerous lives.
ImmuneMed
Inc. is a company that specializes in developing new anti-viral drugs and
in-vitro diagnostics.
ImmuneMed’s patented ‘’ImmuneMed Leptospira
Rapid Kit’’ is designed to detect leptospirosis quickly and accurately in its
early stages using antibodies in the patient’s serum. The
microscopic agglutination test, MAT, a gold standard method for
diagnosing leptospirosis caused by over 200 different serotypes, has the downside
of taking over two hours to reach a diagnosis.
However,
ImmuneMed’s diagnostic kit uses a distinguished technology that detects
leptospirosis by using genus specific antigen, which is created by optimizing
to react with patient’s antibodies well.
Unlike
MAT, it offers visible identification within 15 minutes. Furthermore, it has
been proven through national and international clinical evaluation to have an
over 90% on sensitivity and specificity.
The
pre-test line, located below the test line, removes the possibility of
misinterpreting the test results, leading to higher accuracy.
To use
ImmuneMed’s diagnostic kit, first drop clinical sample onto the diagnostic kit.
As the sample reaches the gold pad area, it is
combined with the gold conjugated antibodies on the pad.
As the
leptospira specific antibody in a sample continues to move toward the test
line, it creates purple lines to indicate leptospirosis positive. Also, the
remaining gold conjugated antibodies of the gold pad
that didn’t react to the antibodies within the sample create a purple band at
the contorl line to indicate the conformity of the test.
ImmuneMed’s
in vitro diagnostic kit was developed through years of continuous R&D, and
is capturing the global spotlight as a patented technology for leading
mankind’s healthier life.
